A phase IIb study of RV-001 for cancer treatment

Trial Profile

A phase IIb study of RV-001 for cancer treatment

Phase of Trial: Phase II

Latest Information Update: 26 Oct 2017

At a glance

  • Drugs RV 001 (Primary)
  • Indications Cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 26 Oct 2017 According to a RhoVac media release, the company is planning to initiate the Scientific Advice procedure early 2018 for this trial based on EMAs recommendation.
    • 10 Nov 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top